Green Thumb Industries Reports Q3 2025 Financial Results and Expands Adult-Use Cannabis Sales

Green Thumb Industries ( (TSE:GTII) ) has provided an update.

Green Thumb Industries reported its financial results for the third quarter of 2025, showing a revenue of $291.4 million, a 1.6% increase from the previous year. The company achieved a GAAP net income of $23.3 million and an adjusted EBITDA of $80.2 million, representing 27.5% of revenue. Significant operational highlights include the commencement of adult-use cannabis sales at seven RISE Dispensaries in Minnesota, with the eighth following shortly after. These developments underscore Green Thumb’s strategic expansion in the adult-use cannabis market, potentially enhancing its market positioning and stakeholder value.

The most recent analyst rating on (TSE:GTII) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on Green Thumb Industries stock, see the TSE:GTII Stock Forecast page.

Spark’s Take on TSE:GTII Stock

According to Spark, TipRanks’ AI Analyst, TSE:GTII is a Neutral.

Green Thumb Industries’ overall stock score is driven by strong financial performance and strategic growth initiatives, despite facing valuation challenges and mixed technical indicators. The cautious sentiment from the earnings call reflects ongoing industry challenges, but the company’s focus on long-term growth and market expansion provides a balanced outlook.

To see Spark’s full report on TSE:GTII stock, click here.

More about Green Thumb Industries

Green Thumb Industries Inc. is a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries. The company operates within the cannabis industry, focusing on both medical and adult-use cannabis sales across various states, including Minnesota.

Average Trading Volume: 193,017

Technical Sentiment Signal: Sell

Current Market Cap: C$2.2B

See more data about GTII stock on TipRanks’ Stock Analysis page.